Device Trial Radar · NCT05906004
Post-Market Clinical Follow-up (PMCF) Study of the Pitch-Patch for the Augmentation or Reinforcement of the Rotator Cuff
Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
37
Planned (sponsor's estimate)
Start
Jun 16, 2026
Primary completion
Nov 2029
Study completion Dec 2029
Sponsor
- Lead sponsor
- Xiros LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 15, 2023
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical investigation study. It will verify the long-term safety and performance of the Pitch-Patch when implanted to reinforce partially repairable rotator cuff tears and used as described by the manufacturer's instructions. The medical device in this study is already on the market and is manufactured by Xiros Ltd. The Pitch-Patch is a single-use polyester prosthesis available in two sizes (30x20mm and 35x25mm). It is reinforced around the perimeter and around each eyelet to provide strength and stability to the device and repair. The study will collect data on patients who meet the entry criteria and have received the device. This is a single-armed study, meaning all patients will have a Pitch-Patch. The total length of the study is expected to be 3 years. A minimum of 37 patients will be enrolled into the study. Patients will be enrolled at a study specific follow up visit 2-2.5 years after implant, and data for baseline, procedure, and other time points prior to 2 years (3month, 6month, and 1 year post surgery) will be collected retrospectively from medical records if available.
Conditions
- Rotator Cuff Tear
- Rotator Cuff Tears
- Rotator Cuff Tears of the Shoulder
- Rotator Cuff Injuries
Interventions
Pitch-PatchDevice
Pitch-Patch device used for rotator cuff augmentation/ reinforcement.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Constant Murley Score (CMS)Time frame: 2 years
- Device Related or Procedure Related Adverse EventsTime frame: 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Reading Shoulder Unit
Reading, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.